128 related articles for article (PubMed ID: 27752061)
1. Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
Teng HW; Hung MH; Chen LJ; Chang MJ; Hsieh FS; Tsai MH; Huang JW; Lin CL; Tseng HW; Kuo ZK; Jiang JK; Yang SH; Shiau CW; Chen KF
Sci Rep; 2016 Oct; 6():35308. PubMed ID: 27752061
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
Tai WT; Chen YL; Chu PY; Chen LJ; Hung MH; Shiau CW; Huang JW; Tsai MH; Chen KF
Hepatology; 2016 May; 63(5):1528-43. PubMed ID: 26840794
[TBL] [Abstract][Full Text] [Related]
3. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
4. SHP-1 is a target of regorafenib in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Lin H; Hung MH; Chen YL; Huang JW; Tai WT; Yu HC; Chen KF
Oncotarget; 2014 Aug; 5(15):6243-51. PubMed ID: 25071018
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Neoplasia; 2015 Sep; 17(9):687-696. PubMed ID: 26476076
[TBL] [Abstract][Full Text] [Related]
6. Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ).
Cordeiro HG; de Sousa Faria AV; Ferreira-Halder CV
Biol Chem; 2020 Aug; 401(9):1063-1069. PubMed ID: 32229687
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis.
Chen Q; Li Y; Li Z; Zhao Q; Fan L
J Mol Histol; 2014 Apr; 45(2):153-9. PubMed ID: 23990346
[TBL] [Abstract][Full Text] [Related]
9. A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer.
Ou B; Cheng X; Xu Z; Chen C; Shen X; Zhao J; Lu A
Cell Death Dis; 2019 Sep; 10(9):643. PubMed ID: 31501414
[TBL] [Abstract][Full Text] [Related]
10. The role of protein tyrosine phosphatase 1B in Ras signaling.
Dubé N; Cheng A; Tremblay ML
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1834-9. PubMed ID: 14766979
[TBL] [Abstract][Full Text] [Related]
11. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
Camaj P; Primo S; Wang Y; Heinemann V; Zhao Y; Laubender RP; Stintzing S; Giessen-Jung C; Jung A; Gamba S; Bruns CJ; Modest DP
Future Oncol; 2015; 11(13):1919-29. PubMed ID: 26161928
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
Cho H
Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
[TBL] [Abstract][Full Text] [Related]
13. Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.
Hoekstra E; Das AM; Swets M; Cao W; van der Woude CJ; Bruno MJ; Peppelenbosch MP; Kuppen PJ; Ten Hagen TL; Fuhler GM
Oncotarget; 2016 Apr; 7(16):21922-38. PubMed ID: 26942883
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
Teng HW; Hung MH; Chen LJ; Chang MJ; Hsieh FS; Tsai MH; Huang JW; Lin CL; Tseng HW; Kuo ZK; Jiang JK; Yang SH; Shiau CW; Chen KF
Sci Rep; 2017 Apr; 7():45612. PubMed ID: 28394314
[No Abstract] [Full Text] [Related]
15. Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.
Argilés G; Saunders MP; Rivera F; Sobrero A; Benson A; Guillén Ponce C; Cascinu S; Van Cutsem E; Macpherson IR; Strumberg D; Köhne CH; Zalcberg J; Wagner A; Luigi Garosi V; Grunert J; Tabernero J; Ciardiello F
Eur J Cancer; 2015 May; 51(8):942-9. PubMed ID: 25818084
[TBL] [Abstract][Full Text] [Related]
16. Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
Thiebaut PA; Besnier M; Gomez E; Richard V
J Mol Cell Cardiol; 2016 Dec; 101():50-57. PubMed ID: 27596049
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation.
Zhang J; Li L; Li J; Liu Y; Zhang CY; Zhang Y; Zen K
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):163-74. PubMed ID: 25395617
[TBL] [Abstract][Full Text] [Related]
18. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
Wang C; Wang L; Yang Z
Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
[TBL] [Abstract][Full Text] [Related]
19. Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.
Su JC; Mar AC; Wu SH; Tai WT; Chu PY; Wu CY; Tseng LM; Lee TC; Chen KF; Liu CY; Chiu HC; Shiau CW
Sci Rep; 2016 Jul; 6():28888. PubMed ID: 27364975
[TBL] [Abstract][Full Text] [Related]
20. Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
Napolitano S; Martini G; Rinaldi B; Martinelli E; Donniacuo M; Berrino L; Vitagliano D; Morgillo F; Barra G; De Palma R; Merolla F; Ciardiello F; Troiani T
Clin Cancer Res; 2015 Jul; 21(13):2975-83. PubMed ID: 25838391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
